- Home
- FULTP vs SIGA Comparison
FULTP vs SIGA Comparison
Compare FULTP & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
FULTP
Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Current Price
Company Overview
Basic Information| Metric | FULTP | SIGA |
|---|---|---|
| Founded | N/A | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 223.8M |
| IPO Year | 1995 | 2016 |
Fundamental Metrics
Financial Performance| Metric | FULTP | SIGA |
|---|---|---|
| Price | $17.50 | $2.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.0K | ★ 780.9K |
| Earning Date | N/A | 05-05-2026 |
| Dividend Yield | N/A | ★ 13.24% |
| EPS Growth | ★ 32.48 | N/A |
| EPS | ★ 1.02 | 0.13 |
| Revenue | ★ $276,768,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $224.81 |
| P/E Ratio | ★ $17.23 | $22.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.40 | $2.83 |
| 52 Week High | $20.83 | $9.45 |
Technical Indicators
Market Signals| Indicator | FULTP | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 37.73 | 27.86 |
| Support Level | N/A | N/A |
| Resistance Level | $18.76 | $4.84 |
| Average True Range (ATR) | 0.18 | 0.14 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 18.23 | 8.33 |
Price Performance
Historical ComparisonAbout FULTP Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.